Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3
about
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signalingTranscriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathwayThe Innate Immune System in Acute and Chronic WoundsThe crystal structure of zebrafish IL-22 reveals an evolutionary, conserved structure highly similar to that of human IL-22Interferon-lambdas: the modulators of antivirus, antitumor, and immune responsesDespite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokinesThe T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chainsModulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29)Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cellsCharacterization of the murine alpha interferon gene familyIFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.Update on Janus kinase antagonists in inflammatory bowel disease.Interferon-lambda: a new addition to an old family.Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysisThe cationic cytokine IL-26 differentially modulates virus infection in culture.Identification, Characterization, and Developmental Expression Pattern of Type III Interferon Receptor Gene in the Chinese Goose.The unique regulation and functions of type III interferons in antiviral immunity.Mouse STAT2 restricts early dengue virus replicationInterferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronavirusesThe interferons and their receptors--distribution and regulation.Antiviral type I and type III interferon responses in the central nervous systemInvestigations of interferon-lambda for the treatment of cancer.The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.STAT3: a critical component in the response to Helicobacter pylori infection.BaeR protein acts as an activator of nuclear factor-kappa B and Janus kinase 2 to induce inflammation in murine cell lines.Lambda Interferons: New Cytokines with Old Functions.Contribution of type III interferons to antiviral immunity: location, location, location.IL-22 promotes fibroblast-mediated wound repair in the skin.Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes.Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis.Tanapoxvirus lacking the 15L gene inhibits melanoma cell growth in vitro by inducing interferon-λ1 release.Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells.Human but not mouse hepatocytes respond to interferon-lambda in vivo.The RNA binding protein La/SS-B promotes RIG-I-mediated type I and type III IFN responses following Sendai viral infection.Mutation of IFNLR1, an interferon lambda receptor 1, is associated with autosomal-dominant non-syndromic hearing loss.Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways.Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.The effect of IL-28A on human cord blood CD4+ T cells.
P2860
Q24294509-EA71D012-5D3B-43A9-9A8E-0209B0ABC126Q24622379-AC20B703-5195-4734-ADB9-E8655D5BBAE2Q26767062-659B862C-F0D1-4D54-97DD-1B1EA11C1197Q27690244-2487FF2C-DC66-4BA0-BC80-EFE5B4FC7023Q28238963-AA2AC131-03B6-440B-9921-E958B89E998CQ28260203-FF53A15E-DD0A-47F6-A3CD-00CB630BDEBCQ28265025-F5491588-A1FF-49C3-9CC8-DE238CCF8533Q28272127-3AD0DC23-3BBA-499B-8E1A-E415AA3EA6C1Q28302197-1E49CDC5-117C-4362-BC03-513C85AFD921Q28588580-E0F3DC63-02B7-42D6-A6BD-9428B93C4810Q33325913-E4E6C69F-3998-4C1B-9C9A-35C490C86E1FQ34030650-73120CC4-81E4-4A8F-B070-0071F8CE9135Q34077324-07EF3443-3262-42D3-A68A-5B9859AC977FQ34433087-18EB0946-9171-42AC-BF3C-27CD4FB8CF2EQ34653087-2A192BA7-DBDF-47EC-9DE4-E3AC5867018AQ34854990-21EA97EB-51DF-4E01-9BDC-BFDA7E50C03FQ35639482-632A3E32-AF03-43A3-9B57-ABC157FB0997Q35751815-97C3C756-ACD9-494B-B60F-978E343D2F1AQ35846922-0B62898C-3F6D-4BE2-ADDF-FF6E3676DFA1Q37352688-5D1474F6-999D-4355-B964-277F0DF18BEDQ37992849-E1877097-02B3-4174-9FE0-CA2FD6C22893Q38090421-EB695969-36DA-43C6-B400-AE7C099800FFQ38347596-A16EBEBA-3501-41E1-B890-0D7EC65AFB48Q38514365-6F5821E1-64B7-4A08-A8BE-43EA5AB5AACDQ38579179-ED55E7A4-DEAF-4B19-9380-9BB144834DFBQ38760106-5B5D72E3-9BD6-464D-A88A-BE3B81CCBFF0Q38974225-B9BF931C-BFAB-46CB-81B1-E6E4AD96E3E8Q39176570-B18C872C-1818-4F13-903C-2F6846046E1EQ39391390-F8CE9A2D-6E1F-415B-AF2A-E2D2265DFB64Q39489291-50C71C49-FA03-425F-AAD2-17D3F2F1457FQ39747657-CC4BB26C-FE52-44DA-A5ED-DEA180BCA805Q40336558-2739BAE3-C897-4DB8-9C98-DD2BDFCE2E0FQ40844750-84CB0DE2-9286-4886-9DD4-9DFA36024996Q41904704-AA9B7E92-5866-48F1-9609-89696AFA139CQ46776464-E2124014-6F51-43D4-B5AD-28BD21375FD5Q49915030-42DAEC47-12B7-4B1A-B4F0-79A5A97D71CEQ53327148-854FCA8C-9CA6-43FE-B318-63577C56C9B4Q53404199-4ED960A2-380F-450F-8F3F-D8B215ED5BF5Q53530465-2B64811E-8826-49BF-A4D3-9D270A628A78Q54441842-DF178121-3885-484F-8AB8-832E181FF144
P2860
Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@ast
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@en
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@en-gb
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@nl
type
label
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@ast
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@en
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@en-gb
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@nl
prefLabel
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@ast
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@en
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@en-gb
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@nl
P2093
P2860
P356
P1433
P1476
Cloning of a new type II cytok ...... ption (STAT)1, STAT2 and STAT3
@en
P2093
Diane Lejeune
Helmut Fickenscher
Laure Dumoutier
P2860
P356
10.1042/BJ20021935
P407
P577
2003-03-01T00:00:00Z